Efficacy and safety of topical WBI-1001 in the treatment of atopic dermatitis: results from a phase 2A, randomized, placebo-controlled clinical trial
- PMID: 20404242
- DOI: 10.1001/archdermatol.2010.34
Efficacy and safety of topical WBI-1001 in the treatment of atopic dermatitis: results from a phase 2A, randomized, placebo-controlled clinical trial
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
